Loading...

Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses

B7-H4 inhibits T-cell activation and is widely expressed by solid neoplasms. We have recently demonstrated that the expression of B7-H4 on the surface of malignant cells in vivo is inducible, and that novel anti-B7-H4 recombinant antibodies can reverse the inhibition of tumor-specific T cells. Thus,...

Full description

Saved in:
Bibliographic Details
Main Authors: Dangaj, Denarda, Scholler, Nathalie
Format: Artigo
Language:Inglês
Published: Landes Bioscience 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782523/
https://ncbi.nlm.nih.gov/pubmed/24083083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25913
Tags: Add Tag
No Tags, Be the first to tag this record!